4.2 Article

Placenta-on-a-chip: a novel platform to study the biology of the human placenta

期刊

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
卷 29, 期 7, 页码 1046-1054

出版社

TAYLOR & FRANCIS LTD
DOI: 10.3109/14767058.2015.1038518

关键词

Glucose transfer; microfluidics; organ-on-a-chip; placenta in vitro model; placental barrier

资金

  1. Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH/DHHS
  2. Federal funds from NICHD, NIH [HSN275201300006C]
  3. Seoul National University Bundang Hospital Research Fund [03-2013-001]
  4. National Research Foundation of Korea [2012M3A7B4035286, 2013R1A2A2A04013379]
  5. National Medical Center and Asan Medical Center in Seoul, Republic of Korea
  6. NIH Director's New innovator Award [1DP2HL127720-01]
  7. Perinatology Research Branch
  8. National Research Foundation of Korea [2013R1A2A2A04013379] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Objective: Studying the biology of the human placenta represents a major experimental challenge. Although conventional cell culture techniques have been used to study different types of placenta-derived cells, current in vitro models have limitations in recapitulating organ-specific structure and key physiological functions of the placenta. Here we demonstrate that it is possible to leverage microfluidic and microfabrication technologies to develop a microengineered biomimetic model that replicates the architecture and function of the placenta.Materials and methods: A Placenta-on-a-Chip microdevice was created by using a set of soft elastomer-based microfabrication techniques known as soft lithography. This microsystem consisted of two polydimethylsiloxane (PDMS) microfluidic channels separated by a thin extracellular matrix (ECM) membrane. To reproduce the placental barrier in this model, human trophoblasts (JEG-3) and human umbilical vein endothelial cells (HUVECs) were seeded onto the opposite sides of the ECM membrane and cultured under dynamic flow conditions to form confluent epithelial and endothelial layers in close apposition. We tested the physiological function of the microengineered placental barrier by measuring glucose transport across the trophoblast-endothelial interface over time. The permeability of the barrier study was analyzed and compared to that obtained from acellular devices and additional control groups that contained epithelial or endothelial layers alone.Results: Our microfluidic cell culture system provided a tightly controlled fluidic environment conducive to the proliferation and maintenance of JEG-3 trophoblasts and HUVECs on the ECM scaffold. Prolonged culture in this model produced confluent cellular monolayers on the intervening membrane that together formed the placental barrier. This in vivo-like microarchitecture was also critical for creating a physiologically relevant effective barrier to glucose transport. Quantitative investigation of barrier function was conducted by calculating permeability coefficients and metabolic rates in varying conditions of barrier structure. The rates of glucose transport and metabolism were consistent with previously reported in vivo observations.Conclusion: The Placenta-on-a-Chip microdevice described herein provides new opportunities to simulate and analyze critical physiological responses of the placental barrier. This system may be used to address the major limitations of existing placenta model systems and serve to enable research platforms for reproductive biology and medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据